FEB 10, 2021 7:43 PM PST

Cross-Reactive Antibodies Don't Protect Against COVID

WRITTEN BY: Tara Fernandez

Did you know that hundreds of viruses can cause the common cold? Rhinovirus, adenovirus, and coronavirus infections can result in the sniffles, sneezing, and watery eyes associated with having the seasonal disease.

As the pandemic began to gain momentum, scientists hypothesized that being exposed to seasonal coronaviruses that cause the cold could also potentially provide individuals with immunological protection against the emergent SARS-CoV-2. 

Now, a study led by microbiologists from the University of Pennsylvania has shown that, unfortunately, antibodies produced by prior coronavirus infections cannot neutralize the strain that causes COVID-19. The research was published in Cell.

"We found that many people possessed antibodies that could bind to SARS-CoV-2 before the pandemic, but these antibodies could not prevent infections," said the study lead, Scott Hensley.

"Although antibodies from prior coronavirus infections cannot prevent SARS-CoV-2 infections, it is possible that pre-existing memory B cells and T cells could potentially provide some level of protection or at least reduce the disease severity of COVID-19. Studies need to be completed to test that hypothesis."

The scientists screened hundreds of blood samples obtained from individuals before the pandemic hit to pan for cross-reactive coronavirus antibodies—Ones that could bind to and inactivate both regular coronaviruses and SARS-CoV-2. Though 20 percent of these antibodies could target antigens on both classes of viruses, these cross-reactive antibodies could not prevent COVID-19.

Though it was suspected that the presence of high levels of cross-reactive antibodies conferred children with better protection against COVID-19 symptoms, this study proved this not to be the case. For now, the reasons why some people experience the symptoms more severely than others are still up in the air, although antibodies are not likely contributors.

The authors call for follow-up studies to take a closer look at how other immune components such as T cells influence cross-reactive protection after a common cold.

 

 

Sources: Eurekalert via University of Pennsylvania, Cell.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
NOV 24, 2020
Immunology
Dirty Sheets Make Babies Healthier
NOV 24, 2020
Dirty Sheets Make Babies Healthier
Microbiologists have established that the development of infants’ immune systems is intricately linked to the dive ...
DEC 07, 2020
Cell & Molecular Biology
An Autoimmune Link to Heart Disease is ID'ed
DEC 07, 2020
An Autoimmune Link to Heart Disease is ID'ed
CNIC researchers have found that there is an autoimmune link to cardiovascular disease that may improve diagnostic and t ...
FEB 03, 2021
Clinical & Molecular DX
New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy
FEB 03, 2021
New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy
Rheumatoid arthritis, or RA, is a painful and debilitating autoimmune disorder of the joints, particularly those of the ...
FEB 10, 2021
Drug Discovery & Development
Genetics Affect Response to Cancer Immunotherapy
FEB 10, 2021
Genetics Affect Response to Cancer Immunotherapy
Researchers have found that genetic factors may dictate as much as 20% of the efficacy of checkpoint inhibitors, a kind ...
FEB 25, 2021
Immunology
Asthma Inhalers Slash Risk of COVID Hospitalization by 90 Percent
FEB 25, 2021
Asthma Inhalers Slash Risk of COVID Hospitalization by 90 Percent
For mild cases of COVID, doctors recommend the usual regimen for getting through a cold or flu: Staying hydrated and res ...
Loading Comments...